My Watchlist
Indicators
EL&P Market Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Omnicell, Inc. - Common Stock (NQ:OMCL)

29.92 UNCHANGED
Streaming Delayed Price Updated: 12:46 PM EDT, Oct 16, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Omnicell, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >
Omnicell Announces Second Quarter 2024 Results
From Omnicell, Inc.
Via Business Wire
3 Russell 2000 Stocks to Buy at a 52-week Low in July
The Russell 2000 is trailing the Nasdaq Composite and S&P500, yet there are still plenty of Russel stocks worth looking into. 
Via InvestorPlace
Topics Stocks
Omnicell to Release Second Quarter 2024 Financial Results on August 1, 2024
From Omnicell, Inc.
Via Business Wire
Omnicell Supports Global Charity Mercy Ships with Pharmacy Technology Donation
From Omnicell, Inc.
Via Business Wire
Earnings Scheduled For February 8, 2024
Companies Reporting Before The Bell • Ares Management (NYSE:ARES) is expected to report quarterly earnings at $1.09 per share on revenue of $864.54 million. 
Via Benzinga
Piper Sandler Upgrades Omnicell: Here's What You Need To Know
 
Via Benzinga
Analyst Expectations for Omnicell's Future
 
Via Benzinga
Omnicell to Present at the BofA Securities 2024 Health Care Conference
From Omnicell, Inc.
Via Business Wire
OMCL Stock Earnings: Omnicell Beats EPS, Beats Revenue for Q1 2024
OMCL stock results show that Omnicell beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. 
Via InvestorPlace
Omnicell Announces First Quarter 2024 Results
From Omnicell, Inc.
Via Business Wire
Omnicell Announces XT Amplify
From Omnicell, Inc.
Via Business Wire
Omnicell to Release First Quarter 2024 Financial Results on May 2, 2024
From Omnicell, Inc.
Via Business Wire
3 Robotics Stocks That Could Soar as the Technology Advances
Discover three robotics stocks set for significant growth as technology evolves. Don't miss out on these opportunities. 
Via InvestorPlace
Omnicell to Present at the virtual KeyBanc Annual Life Sciences & MedTech Investor Forum
From Omnicell, Inc.
Via Business Wire
Omnicell Announces Fiscal Year and Fourth Quarter 2023 Results
From Omnicell, Inc.
Via Business Wire
Omnicell to Release Fourth Quarter and Full Year 2023 Financial Results on February 8, 2024
From Omnicell, Inc.
Via Business Wire
Omnicell Elects Eileen Voynick to Board of Directors
From Omnicell, Inc.
Via Business Wire
The MACD Indicator: Making Technical Analysis Work
We examine how ordinary investors can use some of Wall Street's best tools like the MACD indicator to beat them at their own game. 
Via InvestorPlace
Omnicell to Present at the Piper Sandler 35th Annual Healthcare Conference
From Omnicell, Inc.
Via Business Wire
The Relative Strength Index (RSI) Indicator: Does It Work?
The Relative Strength Index (RSI) is a contrarian technical analysis indicator that uses prices to find "overbought" and "oversold" assets. 
Via InvestorPlace
Why STAAR Surgical Shares Are Trading Lower By Around 16%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Gainers OmniLit Acquisition Corp. (NASDAQ: OLIT) jumped 53.2% to $15.53. OmniLit announced that its merger with Syntec was approved by shareholders. 
Via Benzinga
Baptist Health Engages Omnicell in an Effort to Enhance Pharmacy Care and Further Gain Control of Medication Supply Chain
From Omnicell, Inc.
Via Business Wire
Omnicell Announces Third Quarter 2023 Results; Updates Fiscal Year 2023 Guidance and Announces Reduction in Force
From Omnicell, Inc.
Via Business Wire
Omnicell to Release Third Quarter 2023 Financial Results on November 2, 2023
From Omnicell, Inc.
Via Business Wire
Airbnb, Blackstone Rise On News They'll Join S&P 500 Index
ABNB and BX will join Sept. 18 as part of a quarterly rebalancing. 
Via Investor's Business Daily
Topics Stocks
Benzinga's Top Ratings Upgrades, Downgrades For October 11, 2023
 
Via Benzinga
Omnicell Inc. Unusual Options Activity: Slightly OTM Call Buying With Relative Size
Omnicell Inc. (NASDAQ: OMCL) experienced notable options activity. The majority of the trading volume centered around a single trade involving 300 contracts at a strike price of $60, with a premium of... 
Via Benzinga
Omnicell to Present at the 2023 Wells Fargo Healthcare Conference
From Omnicell, Inc.
Via Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For August 2, 2023
 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.